The oral administration of AVCP (300, 600, and 900 mg/kg/day) significantly reduced the MDA levels and increasing T-AOC, SOD, and GSH-Px activities, thereby significantly attenuating oxidative stress in colitis mice (Figure 5A–D). The gene discussed is SOD1; the disease is colitis.